Clinical Trial Update: Aspirin for the Prevention of Preeclampsia and Pregnancy Outcomes After Assisted Reproductive Technology [Phase 3]

View source ↗

Summary

Phase 3 trial investigating aspirin for prevention of preeclampsia and pregnancy outcomes after assisted reproductive technology (ART) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Assisted Reproductive Technology-associated Pregnancy Outcomes
• Preeclampsia

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: ART, Pre-Eclampsia | Phase 3 | Status: RECRUITING